Our 2025 focus is on pipeline
Pfizer CEO Says Activist Wants Minimal Changes, Plays Down Fight
Pfizer Inc.’s dispute with activist firm Starboard Value LP isn’t “an aggressive situation,” Chief Executive Officer Albert Bourla said, months after the feared investor disclosed a stake in the company and questioned his management.
19hon MSN
Pfizer CEO Albert Bourla said he had spoken to Robert F. Kennedy Jr. in an effort to “find opportunities on things we can ...
Obesity continues to grab attention at the JP Morgan Healthcare Conference in San Francisco, with both Pfizer and Kailera ...
Monday, three Big Pharma leaders took center stage and addressed concerns about future patent expirations head on.
Clegg, former leader of the centrist Liberal Democrats in England, will be replaced by someone much closer to the Trump way ...
shares rise 3.7% after profit forecast Company expects 2025 adjusted profit of $2.80 to $3 per share Pfizer forecasts 2025 revenue $61 billion to $64 billion Pfizer CEO Albert Bourla told analysts ...
Welcome to day 1 of the J.P. Morgan Healthcare Conference, the industry's most significant dealmaking event each year. | For ...
Stan Polovets highlights the Genesis Prize's role in celebrating Jewish excellence and driving global impact through ...
CEO Albert Bourla expressed modest optimism for Pfizer’s 2025 revenues at JPM 2025, supported by plans to prioritize R&D in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback